MedTechIQ: Business, SBIR/STTR and Funding Opportunities

Reaction to Senate healthcare vote offers a preview of 2010 campaigns - Los Angeles Times

Washington Post

Reaction to Senate healthcare vote offers a preview of 2010 campaigns Los Angeles Times LeMieux's unwillingness to even discuss the issue of health insurance in our country -- which has been on the minds of Floridians for many years -- shows ... Democratic Senators For Sale - $100 Million Each! Politics Today: The Health Care Bill's First Test in the Senate The Early Word: Health Bill Digest  - -

Health care: 2010 elections start here - The Swamp (blog)

Hurriyet Daily News

Health care: 2010 elections start here The Swamp (blog) For the Republicans, the midterms will be presented as a chance to retake at least part of Congress from a government trying to take over more than health ... ROUNDTABLE: Grade Obama's first months Democrats Repeating Republican Mistakes Open Letter Re Health Care Reform  - -

Gauging impact of stimulus cash on local economy depends on who you ask - Delaware County Daily Times

TPM LiveWire (blog)

Gauging impact of stimulus cash on local economy depends on who you ask Delaware County Daily Times Joe Sestak, D-7, of Edgmont, advocated for a larger stimulus plan in January and February and is now pushing for additional spending to extend health and ... Stimulus package should focus on jobs. Now. Roads to nowhere: Stimulus dollar magic OUR VIEW - Stimulus isn't all it could be  - -

Activaero, GmbH: Series A $15.9M

Activaero (Germany) a commercial-stage medical device company focused on patient-tailored controlled breathing and inhaled therapeutic delivery systems, closed a $15.9M Series A financing. Participants include BioMedPartners, VI Partners, Abalis Finance and Vesalius Biocapital.

3Q09 OnBioVC | Trend Analysis Now Available

Hot off the press! The 3Q09 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $1,663M flowed into early-stage biopharma, diagnostic and device companies in the third quarter of 2009 and over $4,806M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who you [...]

September 2009 OnBioVC | Trend Analysis Now Available

Hot off the press! The September 2009 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $465M flowed into early-stage biopharma, diagnostic and device companies in the ninth month of 2009 and over $4,806M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who [...]

Celladon, Inc.: Series C $21.8M

Celladon (La Jolla, CA) a clinical-stage company focused on gene therapy for congestive heart failure, closed a $21.8M Series C financing. Participants include Enterprise Partners Venture Capital, Venrock and Johnson & Johnson Dev Corp.

Quanta Fluid Solutions, Ltd.: Series A $14.3M

Quanta Fluid Solutions (United Kingdom) a development-stage medical device company focused on haemodialysis systems for acute renal failure, has closed a $14.3M Series A financing. Participants include NBGI Ventures, Seroba Kernel Life Sciences, Wellington Partners Venture Capital and Brains-To-Ventures.